![]() |
市场调查报告书
商品编码
1896189
分子育种市场预测至2032年:按作物类型、技术、应用、最终用户和地区分類的全球分析Molecular Breeding Market Forecasts to 2032 - Global Analysis By Crop Type (Cereals & Grains, Oilseeds & Pulses, Fruits & Vegetables, Forage & Fodder, and Other Crop Types), Technology, Application, End User and By Geography |
||||||
根据 Stratistics MRC 预测,全球分子育种市场规模预计在 2025 年达到 98.7 亿美元,到 2032 年将达到 339.7 亿美元,预测期内复合年增长率 (CAGR) 为 19.3%。分子育种是一种先进的动植物改良方法,它利用分子生物学工具更精确地辨识、选择和组合理想的遗传性状。分子育种整合了标记辅助选择、基因组选择和 DNA 定序等技术,加速了传统的育种过程。透过靶向与产量、品质、抗病性和抗逆性相关的特定基因,分子育种缩短了育种时间,提高了效率,并有助于培育适应不同环境和农业条件的优良品种。
对能够抵御气候变迁的永续农业的需求
农民和政府正将永续农业系统列为优先事项,以确保长期粮食安全。分子育种技术能够精准辨识并选择所需性状,从而快速培育出气候适应型作物。人们对资源高效型农业的日益关注,推动了先进育种技术的应用。公共和私人对永续农业研发的投资,进一步增强了市场动力。减少化学投入的需求,也促使人们关注具有遗传耐受性的品种。这些因素共同作用,显着扩大了全球分子育种市场在不同农业气候区域的规模。
高昂的初始成本和基础建设需求
对基因分型平台和数据分析工具等先进基础设施的需求增加了营运成本。由于资金有限,中小规模的育种计画往往难以采用这些技术。在发展中地区,研究设施的匮乏进一步阻碍了技术的大规模应用。高昂的技术授权和智慧财产权费用也加重了经济负担。漫长的研发週期会延迟市场参与企业的投资报酬率。这些成本相关的挑战仍然是技术更广泛应用的障碍,尤其是在资源匮乏的机构中。
生物强化和营养增强作物
分子育种技术描述了提高主粮作物中铁、锌、维生素和其他营养素等微量元素含量的精确方法。营养强化品种可以在不改变传统饮食习惯的情况下解决隐性饥饿(营养不良)问题。各国政府和国际组织正在支持以改善公众健康为目标的营养育种倡议。基因组学的进步使得快速识别与营养性状相关的基因成为可能。研究机构和种子企业之间的合作正在加速改良作物的商业化。人们对营养日益增长的关注为分子育种市场创造了巨大的成长机会。
来自其他育种技术的竞争
CRISPR等技术能够更快、更精准地开发特定应用所需的性状。一些育种者正将投资转向下一代工具,以缩短产品开发週期。每项技术的监管不确定性可能会影响其区域应用模式。技术创新的快速发展给分子育种服务提供者带来了持续提升自身能力的压力。育种平台之间差异化程度有限,可能导致竞争对手之间相互竞争。替代技术的涌现也可能对分子育种解决方案的长期优势构成挑战。
新冠疫情扰乱了农业研究活动,由于田间试验受限,育种测试也因此延误。供应链中断影响了实验室试剂和育种材料的供应。然而,这场危机凸显了建构韧性粮食系统的重要性,并加速了人们对先进育种技术的兴趣。研究机构加快了数据分析和远端协作数位化工具的应用。资金优先事项也进行了重新调整,以确保在不确定时期作物产量和粮食安全。种子企业专注于快速开发抗逆性强、产量高的品种。在后疫情时代,分子育种作为增强农业韧性的策略工具,再次受到关注。
预计在预测期内,提高产量细分市场将占据最大的市场份额。
预计在预测期内,产量改良领域将占据最大的市场份额,因为提高作物产量仍然是面临土地资源限制和粮食需求不断增长的农民的首要目标。分子标记使育种者能够更准确、更有效率地选择高产性状。与传统方法相比,这些技术缩短了培育优良品种所需的时间。世界各国政府都在大力支持以产量为导向的育种,以提高粮食自给率。高产品种还能提高农场的盈利,进而促进其广泛应用。
预计在预测期内,生技公司板块的复合年增长率将最高。
由于生物技术公司对农业生产和经济收入的直接影响,预计在预测期内将实现最高成长率。人口成长给全球作物生产系统带来持续压力。分子育种有助于释放遗传潜力,从而在各种条件下提高产量。农民更倾向于选择产量高且跨季节表现稳定的品种。种子企业正优先发展这一领域,因为其市场接受度高且易于规模化。公共育种计画也致力于提高作物在逆境环境下的产量稳定性。
预计北美地区将在预测期内占据最大的市场份额,因为该地区的公司在基因组学、生物资讯学和分子工具的整合方面处于领先地位。强大的研发能力推动了新型育种解决方案的快速创新和商业化。与农业机构的策略合作正在扩大技术的覆盖范围。不断增长的创业投资投资支持着生物技术主导育种平台的规模化发展。提供客製化性状解决方案的能力正在增强竞争优势。
由于亚太地区高度重视创新和技术应用,预计该地区在预测期内将实现最高的复合年增长率。这些参与企业正利用先进的分子技术来缩短育种週期并提高精准度。对特种和高性能作物日益增长的需求正在推动生物技术主导解决方案的发展。完善的智慧财产权架构鼓励私部门参与。与种子企业的合作正在加速市场渗透。向新兴经济体的扩张正在创造新的收入来源。
According to Stratistics MRC, the Global Molecular Breeding Market is accounted for $9.87 billion in 2025 and is expected to reach $33.97 billion by 2032 growing at a CAGR of 19.3% during the forecast period. Molecular breeding is an advanced plant and animal improvement approach that uses molecular biology tools to identify, select, and combine desirable genetic traits with greater precision. It integrates techniques such as marker-assisted selection, genomic selection, and DNA sequencing to accelerate traditional breeding processes. By targeting specific genes linked to yield, quality, disease resistance, and stress tolerance, molecular breeding reduces breeding time, improves efficiency, and enhances the development of superior varieties suited to diverse environmental and agricultural conditions.
Demand for climate-resilient & sustainable agriculture
Farmers and governments are increasingly prioritizing sustainable agricultural systems to ensure long-term food security. Molecular breeding enables the rapid development of climate-resilient crops by precisely identifying and selecting desirable traits. Rising awareness about resource-efficient farming is encouraging adoption of advanced breeding approaches. Public and private investments in sustainable agriculture research are further strengthening market momentum. The push to reduce chemical inputs is also driving interest in genetically resilient cultivars. Together, these factors are significantly expanding the global molecular breeding market across diverse agro-climatic regions.
High initial costs & infrastructure needs
The need for sophisticated infrastructure such as genotyping platforms and data analytics tools raises operational costs. Small and medium-sized breeding programs often face difficulties in adopting these technologies due to limited financial resources. In developing regions, inadequate research facilities further constrain large-scale implementation. The high cost of technology licensing and intellectual property adds to the financial burden. Long development timelines can delay returns on investment for market players. These cost-related challenges continue to limit broader adoption, particularly among resource-constrained institutions.
Biofortified & nutritionally enhanced crops
Molecular breeding offers precise tools to improve micronutrient content such as iron, zinc, and vitamins in staple crops. Biofortified varieties can address hidden hunger without altering traditional dietary habits. Governments and international organizations are supporting nutrition-focused breeding initiatives to improve public health outcomes. Advances in genomics are enabling faster identification of genes linked to nutritional traits. Collaboration between research institutes and seed companies is accelerating commercialization of enhanced crops. This growing focus on nutrition presents significant growth opportunities for the molecular breeding market.
Competition from alternative breeding tech
Techniques like CRISPR offer faster trait development with greater precision in certain applications. Some breeders are shifting investments toward these next-generation tools to shorten product development cycles. Regulatory uncertainty around different technologies can influence adoption patterns across regions. The rapid pace of innovation increases pressure on molecular breeding providers to continuously upgrade capabilities. Limited differentiation between breeding platforms may intensify competitive rivalry. As alternative technologies gain traction, they could challenge the long-term dominance of molecular breeding solutions.
The COVID-19 pandemic disrupted agricultural research activities and delayed breeding trials due to restricted field access. Supply chain interruptions affected the availability of laboratory reagents and breeding materials. However, the crisis underscored the importance of resilient food systems and accelerated interest in advanced breeding technologies. Research organizations increasingly adopted digital tools for data analysis and remote collaboration. Funding priorities shifted toward ensuring crop productivity and food security during uncertain times. Seed companies focused on fast-tracking resilient and high-yield varieties. In the post-pandemic period, molecular breeding is gaining renewed attention as a strategic tool for agricultural resilience.
The yield improvement segment is expected to be the largest during the forecast period
The yield improvement segment is expected to account for the largest market share during the forecast period, due to enhancing crop productivity remains a primary objective for farmers facing land constraints and growing food demand. Molecular markers enable breeders to efficiently select high-yield traits with greater accuracy. These techniques reduce the time required to develop superior varieties compared to conventional methods. Governments are strongly supporting yield-focused breeding to strengthen food self-sufficiency. High-yield varieties also improve farm profitability, encouraging widespread adoption.
The biotechnology firms segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the biotechnology firms segment is predicted to witness the highest growth rate, driven by its direct impact on agricultural output and economic returns. Increasing population levels are placing constant pressure on global crop production systems. Molecular breeding helps unlock genetic potential that enhances productivity under varying conditions. Farmers prefer yield-enhancing varieties that offer consistent performance across seasons. Seed companies prioritize this segment due to faster market acceptance and scalability. Public breeding programs are also focusing on yield stability in stress-prone environments.
During the forecast period, the North America region is expected to hold the largest market share, due to these companies are at the forefront of integrating genomics, bioinformatics, and molecular tools. Strong R&D capabilities enable them to rapidly innovate and commercialize new breeding solutions. Strategic partnerships with agricultural institutes are expanding their technology reach. Increased venture capital funding is supporting the scale-up of biotech-driven breeding platforms. Their ability to offer customized trait solutions enhances competitive advantage.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to their strong focus on innovation and technology adoption. These players leverage advanced molecular techniques to reduce breeding cycles and improve accuracy. Growing demand for trait-specific and high-performance crops favors biotech-led solutions. Supportive intellectual property frameworks are encouraging private sector participation. Collaborations with seed companies are accelerating market penetration. Expansion into emerging economies is opening new revenue streams.
Key players in the market
Some of the key players in Molecular Breeding Market include Bayer AG, KeyGene, Corteva Ag, DanBred, Syngenta, Intertek, KWS SAAT, LemnaTec, Limagrain, SGS SA, Eurofins, LGC Limited, Illumina, Inc., Charles Ri, and Thermo Fi.
In October 2025, SALIC and Syngenta Signed Agreement to Explore Joint Agriculture Projects that Enhance Food Security in Saudi Arabia and Around the World. This collaboration with Syngenta reflects SALIC's commitment to innovation, sustainability, and global partnerships. Together, we aim to help transform agriculture by integrating technology, knowledge, and responsible practices empowering farmers, conserving resources, and building resilient food systems that strengthen Saudi Arabia's food security and support future generations worldwide.
In August 2025, DuPont de Nemours, Inc., and Corteva, Inc. announced a settlement to comprehensively resolve all pending environmental and other claims by the State of New Jersey against the Companies in various litigation matters and other state directives. The Settlement will resolve all legacy contamination claims related to the companies' current and former operating sites (Chambers Works, Parlin, Pompton Lakes and Repauno) and claims of statewide PFAS contamination unrelated to those sites, including from the use of aqueous film forming foam.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.